Status:
COMPLETED
Congenital Heart Defects and NIRS
Lead Sponsor:
Petja Fister, MD, PhD
Conditions:
Heart Defects, Congenital
Eligibility:
All Genders
1-4 years
Brief Summary
Congenital Heart Defects and NIRS
Detailed Description
Brain, kidney and intestinal tissue oxygenation in newborns with congenital heart defects assessed by near-infrared spectroscopy.
Eligibility Criteria
Inclusion
- Investigators included term newborns with critical structural CHD (of different types) who required surgical or transcatheter procedure in the first year of life. CHD were diagnosed by pediatric cardiologist by clinical examination and echocardiography.
Exclusion
- The exclusion criteria were pulmonary or neurological disease, perinatal asphyxia, acute illness, prematurity and congenital abnormality other than CHD.
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2014
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03411512
Start Date
December 1 2012
End Date
May 31 2014
Last Update
January 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Ljubljana
Ljubljana, Slovenia, 1000